These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 360752)

  • 21. Growth hormone and somatomedin levels in acromegalics treated with bromocriptine.
    Shalet SM; Price DA; Beardwell CG; Mindel A; MacFarlane IA
    Horm Res; 1980; 12(3):121-9. PubMed ID: 6768666
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term treatment of acromegaly with bromocriptine.
    Eskildsen PG; Svendsen PA; Vang L; Nerup J
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):687-700. PubMed ID: 417539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of bromocriptine on serum hormones in acromegaly.
    Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
    Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bromocriptine and glucose tolerance in acromegalics.
    Dolecek R; Kubis M; Sajnar J; Závada M
    Pharmatherapeutica; 1982; 3(2):100-6. PubMed ID: 7048336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bromocriptine therapy in eleven patients with acromegaly.
    Lundin L; Ljunghall S; Wide L; Boström H
    Acta Endocrinol Suppl (Copenh); 1978; 216():207-16. PubMed ID: 347863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly.
    Belforte L; Camanni F; Chiodini PG; Liuzzi A; Massara F; Molinatti GM; Müller EE; Silvestrini F
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):235-48. PubMed ID: 405832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of long-term treatment with bromocriptine on the growth hormone response to galanin in patients with acromegaly.
    Giustina A; Doga M; Bussi AR; Licini M; Schettino M
    Acta Endocrinol (Copenh); 1993 Feb; 128(2):131-5. PubMed ID: 7680832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins.
    Dawood MY; Jarrett JC; Choe JK
    Fertil Steril; 1982 Oct; 38(4):415-8. PubMed ID: 6811337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum growth hormone and ultrastructural studies of adenohypophysial tissue in bromocriptine treated acromegalic patients.
    Fanghanel-S G; Larraza O; Arauco R; Esquivel R; Martinez Campos A; Valverde-R C
    Clin Endocrinol (Oxf); 1978 Oct; 9(4):289-96. PubMed ID: 102468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine suppression of plasma growth hormone in acromegaly.
    Dunn PJ; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1977 Oct; 7(4):273-81. PubMed ID: 336245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CV 205-502 in acromegaly.
    Chiodini PG; Attanasio R; Cozzi R; Dallabonzana D; Oppizzi G; Orlandi P; Strada S; Liuzzi A
    Acta Endocrinol (Copenh); 1993 May; 128(5):389-93. PubMed ID: 8100375
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of the acute effects of octreotide, bromocriptine and both drugs in combination on growth hormone secretion in acromegaly.
    Wagenaar AH; Harris AG; van der Lely AJ; Lamberts SW
    Acta Endocrinol (Copenh); 1991 Dec; 125(6):637-42. PubMed ID: 1789059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of Ritalin, CB-154 and various drugs of serum GH in acromegalics (author's transl)].
    Kanatsuka A; Makino H; Matsushima Y; Osegawa M; Yamamoto M; Kumagai A
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):636-47. PubMed ID: 99332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
    Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
    Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of adding dopamine agonist therapy to long-acting somatostatin analogues in the management of acromegaly.
    Selvarajah D; Webster J; Ross R; Newell-Price J
    Eur J Endocrinol; 2005 Apr; 152(4):569-74. PubMed ID: 15817912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of bromocriptine on insulin secretion and glucose tolerance in patients with acromegaly.
    Feek CM; Bevan JS; Taylor S; Brown NS; Baird JD
    Clin Endocrinol (Oxf); 1981 Nov; 15(5):473-8. PubMed ID: 7035013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutical effects of bromocriptine (CB 154) in 10 acromegalic subjects. Study of somatotrophic function and clinical survey (author's transl)].
    Fossati P; Asfour M; Brion-Brevan B; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Blacker C
    Ann Endocrinol (Paris); 1977; 38(4):291-301. PubMed ID: 332054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR) for the treatment of acromegaly.
    Plöckinger U; Quabbe HJ
    J Endocrinol Invest; 1991 Dec; 14(11):943-8. PubMed ID: 1806612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acromegaly--results of long term treatment with bromocriptine.
    Besser GM; Wass JA; Thorner MO
    Acta Endocrinol Suppl (Copenh); 1978; 216():187-98. PubMed ID: 347861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.